Nautilus Biotechnology (NAUT) Times Interest Earned (2020 - 2021)

Nautilus Biotechnology (NAUT) reported Times Interest Earned of -$5.93 for Q1 2021, down 724.02% sequentially from -$0.72 in Q4 2020.

Nautilus Biotechnology (NAUT) Times Interest Earned (2020 - 2021) Analysis & Trends

Nautilus Biotechnology (NAUT) has 2 years of Times Interest Earned data on file, last reported at -$5.93 in Q1 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Times Interest Earned (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	658.42
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	7.60
4	NuCana	279.75 Bn	279.75 Bn	-	-0.22
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	2.71
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	22.72
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	-
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-0.38
10	Nautilus Biotechnology	224.14 Mn	224.14 Mn	-	-

Download Data